{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T22:25:00Z","timestamp":1776119100227,"version":"3.50.1"},"reference-count":69,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.diabres.2010.05.022","type":"journal-article","created":{"date-parts":[[2010,7,6]],"date-time":"2010-07-06T08:40:14Z","timestamp":1278405614000},"page":"201-208","source":"Crossref","is-referenced-by-count":31,"title":["The cardiorenal syndrome in diabetes mellitus"],"prefix":"10.1016","volume":"89","author":[{"given":"Hussein H.","family":"Karnib","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuad N.","family":"Ziyadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2010.05.022_bib1","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/ncpneph0803","article-title":"Cardiorenal and renocardiac syndromes: the need for a comprehensive classification and consensus","volume":"4","author":"Ronco","year":"2008","journal-title":"Nat Clin Pract Nephrol"},{"key":"10.1016\/j.diabres.2010.05.022_bib2","series-title":"Diabetes Atlas","author":"Sicree","year":"2008"},{"key":"10.1016\/j.diabres.2010.05.022_bib3","unstructured":"United States Renal Data System, USRDS. Annual data report. Bethesda, MD, 2007. http:\/\/www.kidney.niddk.nih.gov [accessed 15.10.09]."},{"issue":"Suppl. 1","key":"10.1016\/j.diabres.2010.05.022_bib4","first-page":"S79","article-title":"Nephropathy in diabetes","volume":"27","author":"Molitch","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2010.05.022_bib5","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1053\/j.ajkd.2008.01.011","article-title":"Predictive power of sequential measures of albuminuria for progression to ESRD or death in Pima Indians with type 2 diabetes","volume":"51","author":"Pavkov","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.diabres.2010.05.022_bib6","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1161\/CIRCULATIONAHA.106.179294","article-title":"Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association","volume":"115","author":"Buse","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.diabres.2010.05.022_bib7","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1136\/bmj.324.7343.939","article-title":"Comparison of cardiovascular risk between patients with type 2 diabetes and those who had had a myocardial infarction: cross sectional and cohort studies","volume":"324","author":"Evans","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.diabres.2010.05.022_bib8","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1056\/NEJM199812033392314","article-title":"Diabetes and coronary heart disease","volume":"339","author":"Simons","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2010.05.022_bib9","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.2337\/dc06-2558","article-title":"Incidence of coronary heart disease in type 2 diabetic men and women: impact of microvascular complications, treatment, and geographic location","volume":"30","author":"Avogaro","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2010.05.022_bib10","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1136\/bmj.39478.378241.BE","article-title":"Risk of microalbuminuria and progression to macroalbuminuria in a cohort with childhood onset type 1 diabetes: prospective observational study","volume":"336","author":"Amin","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.diabres.2010.05.022_bib11","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.38070.450891.FE","article-title":"Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study","volume":"328","author":"Hovind","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.diabres.2010.05.022_bib12","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1523-1755.2003.00712.x","article-title":"Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64)","volume":"63","author":"Adler","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.diabres.2010.05.022_bib13","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1161\/01.CIR.0000031732.78052.81","article-title":"Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population","volume":"106","author":"Hillege","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.diabres.2010.05.022_bib14","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1136\/bmj.313.7060.779","article-title":"Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study","volume":"313","author":"Rossing","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.diabres.2010.05.022_bib15","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1001\/archinte.157.13.1413","article-title":"The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus: a systematic overview of the literature","volume":"157","author":"Dinneen","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.diabres.2010.05.022_bib16","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/jama.286.4.421","article-title":"for the HOPE study investigators. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals","volume":"286","author":"Gerstein","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.diabres.2010.05.022_bib17","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S0140-6736(02)08090-X","article-title":"Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint Reduction in Hypertension Study (LIFE): a randomised trial against atenolol","volume":"359","author":"Lindholm","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.diabres.2010.05.022_bib18","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1046\/j.1523-1755.1999.00773.x","article-title":"Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency","volume":"56","author":"Culleton","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.diabres.2010.05.022_bib19","doi-asserted-by":"crossref","first-page":"629","DOI":"10.7326\/0003-4819-134-8-200104170-00007","article-title":"Renal insufficiency as a predictor of cardiovascular outcomes and the impact of Ramipril: the HOPE randomized trial","volume":"134","author":"Mann","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.diabres.2010.05.022_bib20","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0735-1097(02)02663-3","article-title":"Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community","volume":"41","author":"Manjunath","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.diabres.2010.05.022_bib21","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1681\/ASN.V122218","article-title":"Renal function and intensive lowering of blood pressure in hypertensive participants of the Hypertension Optimal Treatment (HOT) Study","volume":"12","author":"Ruilope","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.diabres.2010.05.022_bib22","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1046\/j.1523-1755.2002.00522.x","article-title":"Cardiovascular disease risk status in elderly persons with renal insufficiency","volume":"62","author":"Shlipak","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.diabres.2010.05.022_bib23","doi-asserted-by":"crossref","unstructured":"Reis SE, Olson MB, Fried L, Reeser V, Mankad S, Pepine CJ, et al. Mild renal insufficiency is associated with angiographic coronary artery disease in women circulation. 2002; 105:2826\u20139.","DOI":"10.1161\/01.CIR.0000021597.63026.65"},{"key":"10.1016\/j.diabres.2010.05.022_bib24","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJM199005313222203","article-title":"Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study","volume":"322","author":"Levy","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2010.05.022_bib25","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1053\/ajkd.1998.v32.pm9820470","article-title":"Clinical epidemiology of cardiovascular disease in chronic renal disease","volume":"32","author":"Foley","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.diabres.2010.05.022_bib26","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2010.05.022_bib27","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1523-1755.2000.00173.x","article-title":"Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients","volume":"58","author":"Cheung","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.diabres.2010.05.022_bib28","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1016\/j.jacc.2005.11.084","article-title":"Renal impairment and outcomes in heart failure: systematic review and meta-analysis","volume":"47","author":"Smith","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.diabres.2010.05.022_bib29","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1161\/CIRCULATIONAHA.105.580506","article-title":"Renal function as a predictor of outcome in a broad spectrum of patients with heart failure","volume":"113","author":"Hillege","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.diabres.2010.05.022_bib30","doi-asserted-by":"crossref","unstructured":"Schramm TK, Gislason GH, Kober L, Rasmussen S, Rasmussen JN, Abildstrom SZ, et al. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people circulation. 2008; 117:1945\u201354.","DOI":"10.1161\/CIRCULATIONAHA.107.720847"},{"issue":"Suppl. 2","key":"10.1016\/j.diabres.2010.05.022_bib31","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1007\/PL00002940","article-title":"Risk factors for cardiovascular mortality and morbidity: the WHO multinational study of vascular disease in diabetes","volume":"44","author":"Fuller","year":"2001","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2010.05.022_bib32","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1093\/ndt\/gfn692","article-title":"Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective","volume":"24","author":"Ravera","year":"2009","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl. 5","key":"10.1016\/j.diabres.2010.05.022_bib33","doi-asserted-by":"crossref","first-page":"I80","DOI":"10.1161\/01.HYP.13.5_Suppl.I80","article-title":"Prognostic value of serum creatinine and effect of treatment of hypertension on renal function: results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group","volume":"13","author":"Shulman","year":"1989","journal-title":"Hypertension"},{"key":"10.1016\/j.diabres.2010.05.022_bib34","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1046\/j.1523-1755.2003.00838.x","article-title":"Level of kidney function as a risk factor for cardiovascular outcomes in the elderly","volume":"63","author":"Manjunath","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.diabres.2010.05.022_bib35","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1046\/j.1523-1755.2002.00486.x","article-title":"Modest serum creatinine elevation affects adverse outcome after general surgery","volume":"62","author":"O\u2019Brien","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.diabres.2010.05.022_bib36","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/ki.1995.22","article-title":"Clinical and echocardiographic disease in patients starting end-stage renal disease therapy","volume":"47","author":"Foley","year":"1995","journal-title":"Kidney Int"},{"key":"10.1016\/j.diabres.2010.05.022_bib37","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJM199809173391203","article-title":"Poor long-term survival after acute myocardial infarction among patients on long-term dialysis","volume":"339","author":"Herzog","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2010.05.022_bib38","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0895-4356(93)90072-9","article-title":"The influence of sex and diabetes mellitus on survival following acute myocardial infarction: a community-wide perspective","volume":"46","author":"Donahue","year":"1993","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.diabres.2010.05.022_bib39","doi-asserted-by":"crossref","first-page":"555","DOI":"10.7326\/0003-4819-137-7-200210010-00006","article-title":"Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients","volume":"137","author":"Shlipak","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.diabres.2010.05.022_bib40","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1067\/mhj.2002.125513","article-title":"Benefits of aspirin and betablockade after myocardial infarction in patients with chronic kidney disease","volume":"144","author":"McCullough","year":"2002","journal-title":"Am Heart J"},{"key":"10.1016\/j.diabres.2010.05.022_bib41","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1053\/j.ajkd.2005.07.043","article-title":"Outcomes of acute coronary syndrome in a large Canadian cohort: impact of chronic renal insufficiency, cardiac interventions, and anemia","volume":"46","author":"Keough-Ryan","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.diabres.2010.05.022_bib42","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jacc.2003.07.031","article-title":"Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure","volume":"43","author":"Forman","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl. 1","key":"10.1016\/j.diabres.2010.05.022_bib43","first-page":"S38","article-title":"Different roles for TGF-\u03b2 and VEGF in the pathogenesis of the cardinal features of diabetic nephropathy","volume":"82","author":"Fuad","year":"2008","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabres.2010.05.022_bib44","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1053\/meta.2002.34703","article-title":"Glycoxidized low-density lipoprotein enhances monocyte chemoattractant protein-1 mRNA expression in human umbilical vein endothelial cells: relation to lysophosphatidylcholine contents and inhibition by nitric oxide donor","volume":"51","author":"Sonoki","year":"2002","journal-title":"Metabolism"},{"key":"10.1016\/j.diabres.2010.05.022_bib45","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s12263-007-0050-5","article-title":"Chronic hyperglicemia and nitric oxide bioavailability play a pivotal role in pro-atherogenic vascular modifications","volume":"2","author":"Pandolfi","year":"2007","journal-title":"Genes Nutr"},{"key":"10.1016\/j.diabres.2010.05.022_bib46","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1161\/01.CIR.0000027109.14149.67","article-title":"Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase","volume":"106","author":"Lin","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.diabres.2010.05.022_bib47","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1007\/s00125-008-0961-8","article-title":"What is the mechanism of microalbuminuria in diabetes: a role for the glomerular endothelium?","volume":"51","author":"Satchell","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2010.05.022_bib48","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s001250051162","article-title":"Plasma concentration of C-reactive protein is increased in type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation","volume":"42","author":"Schalkwijk","year":"1999","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2010.05.022_bib49","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.2337\/diabetes.51.4.1157","article-title":"Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death","volume":"51","author":"Stehouwer","year":"2002","journal-title":"Diabetes"},{"issue":"Suppl. 1","key":"10.1016\/j.diabres.2010.05.022_bib50","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/j.diabres.2005.03.009","article-title":"Role of endothelial dysfunction in the development of cardiorenal syndrome in patients with type 1 diabetes mellitus","volume":"68","author":"Shestakova","year":"2005","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabres.2010.05.022_bib51","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0140-6736(92)91401-S","article-title":"Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus","volume":"340","author":"Stehouwer","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.diabres.2010.05.022_bib52","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.2337\/dc07-1960","article-title":"Markers of endothelial dysfunction and inflammation in type 1 diabetic patients with or without diabetic nephropathy followed for 10 years: association with mortality and decline of glomerular filtration rate","volume":"31","author":"Astrup","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2010.05.022_bib53","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1161\/hc0902.104718","article-title":"Vascular endothelial growth factor is necessary in the development of arteriosclerosis by recruiting\/activating monocytes in a rat model of long-term inhibition of nitric oxide synthesis","volume":"105","author":"Zhao","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.diabres.2010.05.022_bib54","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1681\/ASN.2006050459","article-title":"Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy","volume":"18","author":"Nakagawa","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.diabres.2010.05.022_bib55","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1161\/hc1102.105264","article-title":"BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy","volume":"105","author":"Gottlieb","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.diabres.2010.05.022_bib56","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"The Diabetes Control Complications Trial Research Group","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2010.05.022_bib57","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","volume":"352","author":"The UK Prospective Diabetes Study (UKPDS) Group","year":"1998","journal-title":"Lancet"},{"issue":"Suppl. 1","key":"10.1016\/j.diabres.2010.05.022_bib58","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.2337\/dc08-S012","article-title":"Standards of medical care in diabetes\u20142008","volume":"31","author":"American Diabetes Association","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2010.05.022_bib59","doi-asserted-by":"crossref","first-page":"421","DOI":"10.7326\/0003-4819-141-6-200409210-00007","article-title":"Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus","volume":"141","author":"Selvin","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.diabres.2010.05.022_bib60","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","author":"Patel","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2010.05.022_bib61","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJMoa0808431","article-title":"The VADT investigators, glucose control and vascular complications in veterans with type 2 diabetes","volume":"350","author":"Duckworth","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2010.05.022_bib62","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","article-title":"Effects of intensive glucose lowering in type 2 diabetes","volume":"358","author":"Gerstein","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2010.05.022_bib63","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1056\/NEJMoa052187","article-title":"Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes","volume":"353","author":"Nathan","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2010.05.022_bib64","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/bmj.317.7160.703","article-title":"Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes, UKPDS, 38","volume":"317","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.diabres.2010.05.022_bib65","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0140-6736(98)04311-6","article-title":"Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the hypertension optimal treatment (HOT) randomised trial","volume":"351","author":"Hansson","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.diabres.2010.05.022_bib66","doi-asserted-by":"crossref","first-page":"614","DOI":"10.2337\/diacare.20.4.614","article-title":"Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease: a subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)","volume":"20","author":"Py\u00f6r\u00e4l\u00e4","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2010.05.022_bib67","doi-asserted-by":"crossref","first-page":"S224","DOI":"10.1097\/01.ASN.0000032544.37147.AE","article-title":"Renal and cardiovascular protection in type diabetes mellitus: angiotensin II receptor blockers","volume":"13","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.diabres.2010.05.022_bib68","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.2337\/db06-1646","article-title":"Reduction in microalbuminuria as an integrated indicator for renal and cardiovascular risk reduction in patients with type 2 diabetes","volume":"56","author":"Araki","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2010.05.022_bib69","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1056\/NEJMoa021778","article-title":"Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes","volume":"348","author":"Gaede","year":"2003","journal-title":"N Engl J Med"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822710002573?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822710002573?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,30]],"date-time":"2021-10-30T20:51:45Z","timestamp":1635627105000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822710002573"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":69,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S0168822710002573"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2010.05.022","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}